Target intelligence / Profile preview

Proline-rich protein 27 (PRR27)

Target
PRR27
Molecular classification
Other — It is classified under protein-coding genes and proline-rich proteins. Not a known receptor, enzyme, transporter, channel, transcription factor, or histone modifier.
01

Overview

Proline-rich protein 27 (PRR27) is a human gene coding for a protein of unknown function, mapped to chromosome 4 (locus 4q25-q27). It is expressed in various tissues and cellular compartments, particularly in the extracellular region, and is noted to be a component of extracellular exosomes. To date, there is no experimental evidence describing its biological role, molecular function, disease mechanism, or clinical utility as a therapeutic target, receptor, or biomarker. Current research does not support its inclusion in drug development pipelines, and clinical or functional data remain limited or absent. If you require structured data for further bioinformatics or drug discovery purposes, key entries such as drug targets, mechanisms, biomarker status, and safety should be set to null or none, unless new evidence emerges.

Other names
PRR27C4orf40proline-rich protein 27chromosome 4 open reading frame 40
02

Mechanism of action

None — No mechanism of action for drugs targeting PRR27 described in available databases.

03

Biological functions

Other — Located mainly in the extracellular region and extracellular exosomes. No specific function has yet been characterized in the literature; ‘function unknown’ or ‘uncharacterized protein’ are commonly noted.
04

Disease associations

OtherHereditary Wilms’ tumor (reported association by GeneCards; the pathogenic role is unclear and not well-established). No broad disease involvement reliably supported in sources.

Beyond the preview

Go deeper on Proline-rich protein 27 (PRR27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline-rich protein 27 (PRR27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call